Bayer Consumer Health licenses MOB-015

14 February 2019 - Deborah Wilkes

Bayer Consumer Health has signed an exclusive European licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.